HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anti-Counterfeiting INFORM Consumers Act Cheered By Personal Care, Consumer Health Industries

Executive Summary

The Personal Care Products Council and the Consumer Healthcare Products Association say the INFORM Consumers Act’s inclusion in US Congress’ December 2022 omnibus spending package is a win for consumers and industry.

You may also be interested in...



Cosmetics Reform In, Dietary Supplements Out Of US Omnibus Spending Bill

The must-pass federal spending bill includes the Modernization of Cosmetics Regulation Act, which previously appeared as a rider in US Food and Drug Administration user-fee legislation but was cut from the final iteration.

US Cosmetics Modernization Bill Relaunched, Now With Fragrance Allergen Labeling, PFAS Ban

The Personal Care Products Safety Act was reintroduced in the US Senate on 17 June with industry support including leading brands at big-name multinationals. The latest “Feinstein bill” for modernizing US cosmetics regulations purports to strengthen counterfeit product protections while floating additional requirements for fragrance allergen labeling and banning intentionally added PFAS.

Counterfeit Cosmetics Are A Click Away; SHOP SAFE Act Would Make E-Commerce Platforms Accountable

The Personal Care Products Council testified on the economic toll of counterfeit cosmetics, as well as potential safety issues, at a US House Judiciary subcommittee meeting on 27 May. The bipartisan, bicameral SHOP SAFE Act under consideration would help to address the problem, bill sponsors say.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153243

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel